Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like Veracyte Launches Campaign To Save Lives Through Early Screening For Lung Cancer September 18, 2017 Novartis AG Rejects Proposition to Create More U.S Jobs June 20, 2017 Guided Therapeutics Ships Five LuViva Advanced Cervical Scans To Chinese Partner April 12, 2017
